| 1 |
25762106 | Validation of 64Cu-DOTA-rituximab injection preparation under good manufacturing practices: a PET tracer for imaging of B-cell non-Hodgkin lymphoma. | 2015 |
1 |
| 2 |
24097872 | A novel engineered anti-CD20 tracer enables early time PET imaging in a humanized transgenic mouse model of B-cell non-Hodgkins lymphoma. | 2013 Dec 15 |
1 |
| 3 |
22231277 | Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL. | 2012 Oct |
1 |
| 4 |
21474325 | [177Lu]DOTA-anti-CD20: labeling and pre-clinical studies. | 2011 Jul |
1 |
| 5 |
19350237 | In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study. | 2009 Sep |
1 |
| 6 |
19690034 | Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas. | 2009 Sep |
1 |
| 7 |
20641770 | Single-walled carbon nanotubes-111In-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-rituximab | 2004 |
1 |